2024
SPPADE symptom prevalence and severity in a diverse sample of patients living with metastatic cancers.
Pachman D, Ruddy K, Grzegorczyk V, Kroenke K, Griffin J, Ridgeway J, Chlan L, Tofthagen C, Leventakos K, Strand J, Austin J, Smith A, Mitchell S, Herrin J, Cheville A. SPPADE symptom prevalence and severity in a diverse sample of patients living with metastatic cancers. Journal Of Clinical Oncology 2024, 42: 11108-11108. DOI: 10.1200/jco.2024.42.16_suppl.11108.Peer-Reviewed Original ResearchSymptom burdenHigh school educationDiverse sample of patientsAmerican Indian/Alaska Native (AI/ANSymptom management interventionsHigh symptom burdenPhysical function impairmentComposite scoreCancer symptom controlTotal symptom burdenSchool educationComposite mean scoresSymptom interventionMetastatic diseaseMetastatic cancerSymptom prevalenceSample of patientsSymptom surveyEmployment statusDisability statusMean scoreICD codesCancer typesManagement interventionsSymptom control
2017
Effectiveness of a Decision Aid in Potentially Vulnerable Patients: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial
Rising K, Hollander J, Schaffer J, Kline J, Torres C, Diercks D, Jones R, Owen K, Meisel Z, Demers M, Leblanc A, Shah N, Inselman J, Herrin J, Montori V, Hess E. Effectiveness of a Decision Aid in Potentially Vulnerable Patients: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial. Medical Decision Making 2017, 38: 69-78. PMID: 28525723, DOI: 10.1177/0272989x17706363.Peer-Reviewed Original ResearchConceptsUsual careHealth literacySecondary analysisAcute coronary syndromeDecision aidOne-thirdChest painCoronary syndromePatient characteristicsSDM interventionsIntervention groupVulnerable patientsHigh school educationPatientsControl groupPhysician trustPatient trustSubgroup effectsArm assignmentVulnerable subgroupsSociodemographic groupsMulticenterTrialsSimilar extentPhysicians